187 related articles for article (PubMed ID: 30103540)
1. The Efficacy of Amifostine against Multiple-Dose Doxorubicin-Induced Toxicity in Rats.
Jaćević V; Dragojević-Simić V; Tatomirović Ž; Dobrić S; Bokonjić D; Kovačević A; Nepovimova E; Vališ M; Kuča K
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30103540
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the protective effects of amifostine and dexrazoxane against the toxicity of doxorubicin in spontaneously hypertensive rats.
Herman EH; Zhang J; Chadwick DP; Ferrans VJ
Cancer Chemother Pharmacol; 2000; 45(4):329-34. PubMed ID: 10755322
[TBL] [Abstract][Full Text] [Related]
3. Amifostine reduces the seminiferous epithelium damage in doxorubicin-treated prepubertal rats without improving the fertility status.
Vendramini V; Sasso-Cerri E; Miraglia SM
Reprod Biol Endocrinol; 2010 Jan; 8():3. PubMed ID: 20064221
[TBL] [Abstract][Full Text] [Related]
4. Histopathological and scintigraphic comparisons of the protective effects of L-carnitine and amifostine against radiation-induced late renal toxicity in rats.
Caloglu M; Yurut-Caloglu V; Durmus-Altun G; Oz-Puyan F; Ustun F; Cosar-Alas R; Saynak M; Parlar S; Turan FN; Uzal C
Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):523-30. PubMed ID: 19673935
[TBL] [Abstract][Full Text] [Related]
5. Amifostine protects against early but not late toxic effects of doxorubicin in infant rats.
Jahnukainen K; Jahnukainen T; Salmi TT; Svechnikov K; Eksborg S; Söder O
Cancer Res; 2001 Sep; 61(17):6423-7. PubMed ID: 11522636
[TBL] [Abstract][Full Text] [Related]
6. Efficiency of amifostine as a protection against doxorubicin toxicity in rats during a 12-day treatment.
Nazeyrollas P; Frances C; Prevost A; Costa B; Lorenzato M; Kantelip JP; Elaerts J; Millart H
Anticancer Res; 2003; 23(1A):405-9. PubMed ID: 12680240
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of amifostine in protection against doxorubicin-induced acute cardiotoxic effects in rats.
Dragojević-Simić V; Dobrić S; Jaćević V; Bokonjić D; Milosavljević I; Kovacević A; Mikić D
Vojnosanit Pregl; 2013 Jan; 70(1):38-45. PubMed ID: 23401928
[TBL] [Abstract][Full Text] [Related]
8. Effects of dexrazoxane and amifostine on evolution of Doxorubicin cardiomyopathy in vivo.
Bjelogrlic SK; Radic J; Radulovic S; Jokanovic M; Jovic V
Exp Biol Med (Maywood); 2007 Dec; 232(11):1414-24. PubMed ID: 18040065
[TBL] [Abstract][Full Text] [Related]
9. Investigation of doxorubicin tissue toxicity: does amifostine provide chemoprotection? An experimental study.
Rigatos SK; Stathopoulos GP; Dontas I; Perrea-Kotsarelis D; Couris E; Karayannacos PE; Deliconstantinos G
Anticancer Res; 2002; 22(1A):129-34. PubMed ID: 12017274
[TBL] [Abstract][Full Text] [Related]
10. In vivo mesna and amifostine do not prevent chloroacetaldehyde nephrotoxicity in vitro.
Yaseen Z; Michoudet C; Baverel G; Dubourg L
Pediatr Nephrol; 2008 Apr; 23(4):611-8. PubMed ID: 18204866
[TBL] [Abstract][Full Text] [Related]
11. Protective mechanisms of atorvastatin against doxorubicin-induced hepato-renal toxicity.
El-Moselhy MA; El-Sheikh AA
Biomed Pharmacother; 2014 Feb; 68(1):101-10. PubMed ID: 24268999
[TBL] [Abstract][Full Text] [Related]
12. Toxicity prevention with amifostine in pediatric osteosarcoma patients treated with cisplatin and doxorubicin.
Gallegos-Castorena S; Martínez-Avalos A; Mohar-Betancourt A; Guerrero-Avendaño G; Zapata-Tarrés M; Medina-Sansón A
Pediatr Hematol Oncol; 2007 Sep; 24(6):403-8. PubMed ID: 17710657
[TBL] [Abstract][Full Text] [Related]
13. Amelioration of doxorubicin-induced cardiac and renal toxicity by pirfenidone in rats.
Giri SN; Al-Bayati MA; Du X; Schelegle E; Mohr FC; Margolin SB
Cancer Chemother Pharmacol; 2004 Feb; 53(2):141-50. PubMed ID: 14564477
[TBL] [Abstract][Full Text] [Related]
14. Brassica nigra plays a remedy role in hepatic and renal damage.
Rajamurugan R; Suyavaran A; Selvaganabathy N; Ramamurthy CH; Reddy GP; Sujatha V; Thirunavukkarasu C
Pharm Biol; 2012 Dec; 50(12):1488-97. PubMed ID: 22978659
[TBL] [Abstract][Full Text] [Related]
15. l-Methionine and silymarin: A comparison of prophylactic protective capabilities in acetaminophen-induced injuries of the liver, kidney and cerebral cortex.
Onaolapo OJ; Adekola MA; Azeez TO; Salami K; Onaolapo AY
Biomed Pharmacother; 2017 Jan; 85():323-333. PubMed ID: 27889232
[TBL] [Abstract][Full Text] [Related]
16. Amifostine-doxorubicin association causes long-term prepubertal spermatogonia DNA damage and early developmental arrest.
Vendramini V; Robaire B; Miraglia SM
Hum Reprod; 2012 Aug; 27(8):2457-66. PubMed ID: 22593430
[TBL] [Abstract][Full Text] [Related]
17. Amifostine protection against doxorubicin cardiotoxicity in rats.
Dragojevic-Simic VM; Dobric SL; Bokonjic DR; Vucinic ZM; Sinovec SM; Jacevic VM; Dogovic NP
Anticancer Drugs; 2004 Feb; 15(2):169-78. PubMed ID: 15075674
[TBL] [Abstract][Full Text] [Related]
18. Direct amifostine effect on renal tubule cells in rats.
Weichert-Jacobsen KJ; Bannowski A; Küppers F; Loch T; Stöckle M
Cancer Res; 1999 Jul; 59(14):3451-3. PubMed ID: 10416609
[TBL] [Abstract][Full Text] [Related]
19. Bradykinin potentiating factor isolated from Buthus occitanus venom has a protective effect against cadmium-induced rat liver and kidney damage.
Bekheet SH; Awadalla EA; Salman MM; Hassan MK
Tissue Cell; 2011 Dec; 43(6):337-43. PubMed ID: 21862094
[TBL] [Abstract][Full Text] [Related]
20. Amifostine improves hemodynamic parameters in doxorubicin-pretreated rabbits.
Potemski P; Polakowski P; Wiktorowska-Owczarek AK; Owczarek J; Płuzańska A; Orszulak-Michalak D
Pharmacol Rep; 2006; 58(6):966-72. PubMed ID: 17220557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
